BeiGene Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

BeiGene Stock Summary

BeiGene competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Beigene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8600 people.

BeiGene Key Financial Ratios

BeiGene Key Balance Sheet Accounts

BeiGene Key Income Statement Accounts

BeiGene Key Cash Accounts

BeiGene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BeiGene's current stock value. Our valuation model uses many indicators to compare BeiGene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BeiGene competition to find correlations between indicators driving BeiGene's intrinsic value. More Info.BeiGene is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, BeiGene's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value BeiGene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

BeiGene Systematic Risk

Today, most investors in BeiGene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BeiGene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BeiGene growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of BeiGene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BeiGene. We use our internally-developed statistical techniques to arrive at the intrinsic value of BeiGene based on widely used predictive technical indicators. In general, we focus on analyzing BeiGene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BeiGene's daily price indicators and compare them against related drivers.

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.